Work

Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer

Year: 2018

Type: article

Study design: Observational Study

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-018-4959-8

Authors: Laura Spring, Andrzej Niemierko, Stephanie Haddad, Megan Yuen, Amy Comander, Kerry Reynolds, Jennifer Shin, Atul Bahn, Elena Brachtel, Michelle Specht, Barbara L. Smith, Alphonse Taghian, Rachel Jimenez, Jeffrey Peppercorn, Steven J. Isakoff, Beverly Moy, Aditya Bardia

Institutions: Harvard University, Massachusetts General Hospital

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Susan G. Komen for the Cure, National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: G5191312607, Harvard Clinical and Translational Science Center, Harvard Clinical and Translational Science Center, Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology

OpenAlex ID: W2891322329

FWCI: 0.844

Cites: 27

Cited by: 22

Related to: 10